# Tolerability, Efficacy and Mucosal Inflammation Associated With Orally Administered Colon Cleansing for Colonoscopy

> **NCT00750763** · PHASE4 · COMPLETED · sponsor: **Fremantle Hospital and Health Service** · enrollment: 676 (actual)

## Conditions studied

- Colonoscopy

## Interventions

- **DRUG:** Colonlytely
- **DRUG:** Picolax/Picoprep
- **DRUG:** Fleet

## Key facts

- **NCT ID:** NCT00750763
- **Lead sponsor:** Fremantle Hospital and Health Service
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 676 (ACTUAL)
- **Last updated:** 2009-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00750763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00750763, "Tolerability, Efficacy and Mucosal Inflammation Associated With Orally Administered Colon Cleansing for Colonoscopy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00750763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*